Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
alirocumab
amgen
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
evolocumab
fda
inclisiran
indiana blog main
indiana top stories
national
pcsk9
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
bristol-myers squibb
cancer
cancer immunotherapy
What
new
wave
3
×
cholesterol
drug
acquire
agreed
billion
biotechs
brings
cash
club
companies
company
compound
continued
crop
deal
drugs
exceeded
expensive
faces
fda
financial
firms
foe
group
haul
healthcare
hint
inhibitors
ipo
joined
known
latest
life
lowering
medco
medicines
met
million
Language
unset
Current search:
wave
×
biotech
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M